Zoledronic Acid Treatment of 5T2MM‐Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Su... von Croucher, Peter I, De Raeve, Hendrik, Perry, Mark J, Hijzen, Anja, Shipman, Claire M, Lippitt, Jennifer, Green, Jonathan, Van Marck, Eric, Van Camp, Ben, Vanderkerken, Karin

Volltext

Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myelom... von SHIPMAN, Claire M, CROUCHER, Peter I

Volltext

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease von Croucher, Peter I., Shipman, Claire M., Van Camp, Ben, Vanderkerken, Karin

Volltext

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma von Croucher, Peter I., Shipman, Claire M., Lippitt, Jennifer, Perry, Mark, Asosingh, Kewal, Hijzen, Anja, Brabbs, Alex C., van Beek, Edwin J.R., Holen, Ingunn, Skerry, Timothy M., Dunstan, Colin R., Russell, Graham R., Van Camp, Ben, Vanderkerken, Karin

Volltext

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway von SHIPMAN, C. M, CROUCHER, P. I, RUSSELL, R. G. G, HELFRICH, M. H, ROGERS, M. J

Volltext

Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S‐phase arrest, in human myeloma cells von Roelofs, Anke J., Hulley, Philippa A., Meijer, Annemieke, Ebetino, Frank H., Russell, R. Graham G., Shipman, Claire M.

Volltext

Bisphosphonates - Mechanisms of Action in Multiple Myeloma von SHIPMAN, Claire M, ROGERS, Michael J, VANDERKERKEN, Karin, VAN CAMP, Ben, RUSSELL, R. Graham G, CROUCHER, Peter I

Volltext

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma von SHIPMAN, Claire M, VANDERKERKEN, Karin, ROGERS, Michael J, LIPPITT, Jennifer M, ASOSINGH, Kewal, HUGHES, David E, VAN CAMP, B. E. N, RUSSELL, R. Graham G, CROUCHER, Peter I

Volltext

Advances in the management of myeloma bone disease von Shipman, Claire M, Oyajobi, Babatunde O, Mundy, Gregory R

Volltext

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity von Shipman, Claire M., Rogers, Michael J., Apperley, Jane F., Russell, R. Graham G., Croucher, Peter I.

Volltext

The bisphosphonate–ester apomine does not act by inhibiting protein prenylation, but enhances the effects of lovastatin on myeloma cells von Roelofs, Anke J., Hulley, Philippa A., Graham, R., Russell, G., Shipman, Claire M.

Volltext

Reply to salomo and gimsing von Shipman, Claire M., Croucher, Peter I., Vanderkerken, Karin

Volltext

Bisphosphonates and in vivo models of mulitple myeloma / reply von Salomo, Morten, Gimsing, Peter, Shipman, Claire M, Croucher, Peter I, Vanderkerken, Karin

Volltext

Anti-Tumour Activity of Bisphosphonates in Human Myeloma Cells von Shipman, Claire M., Rogers, Michael J., Apperley, Jane F., Russell, R. Graham G., Croucher, Peter I.

Volltext

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma von Shipman, Claire M., Vanderkerken, Karin, Rogers, Michael J., Lippitt, Jennifer M., Asosingh, Kewal, Hughes, David E., Russell, R. Graham G., Croucher, Peter I.

Volltext

Recent insights into myeloma bone disease von Oyajobi, Babatunde O, Shipman, Claire M, Mundy, Gregory R

Volltext

Surveillance of Vermont wildlife in 2021–2022 reveals no detected SARS-CoV-2 viral RNA von Despres, Hannah W., Mills, Margaret G., Schmidt, Madaline M., Gov, Jolene, Perez, Yael, Jindrich, Mars, Crawford, Allison M. L., Kohl, Warren T., Rosenblatt, Elias, Kubinski, Hannah C., Simmons, Benjamin C., Nippes, Miles C., Goldenberg, Anne J., Murtha, Kristina E., Nicoloro, Samantha, Harris, Mia J., Feeley, Avery C., Gelinas, Taylor K., Cronin, Maeve K., Frederick, Robert S., Thomas, Matthew, Johnson, Meaghan E., Murphy, James, Lenzini, Elle B., Carr, Peter A., Berger, Danielle H., Mehta, Soham P., Floreani, Christopher J., Koval, Amelia C., Young, Aleah L., Fish, Jess H., Wallace, Jack, Chaney, Ella, Ushay, Grace, Ross, Rebecca S., Vostal, Erin M., Thisner, Maya C., Gonet, Kyliegh E., Deane, Owen C., Pelletiere, Kari R., Rockafeller, Vegas C., Waterman, Madeline, Barry, Tyler W., Goering, Catriona C., Shipman, Sarah D., Shiers, Allie C., Reilly, Claire E., Duff, Alanna M., Madruga, Sarah L., Shirley, David J., Jerome, Keith R., Pérez-Osorio, Ailyn C., Greninger, Alexander L., Fortin, Nick, Mosher, Brittany A., Bruce, Emily A.

Volltext

ß-Adrenergic receptor signaling increases NAADP and cADPR levels in the heart von Lewis, Alexander M., Aley, Parvinder K., Roomi, Ali, Thomas, Justyn M., Masgrau, Roser, Garnham, Clive, Shipman, Katherine, Paramore, Claire, Bloor-Young, Duncan, Sanders, Luke E.L., Terrar, Derek A., Galione, Antony, Churchill, Grant C.

Volltext

The pharmacology of bisphosphonates and new insights into their mechanisms of action von Russell, R. Graham G., Rogers, Michael J., Frith, Julie C., Luckman, Steven P., Coxon, Fraser P., Benford, Helena L., Croucher, Peter I., Shipman, Claire, Fleisch, Herbert A.

Volltext

β-Adrenergic receptor signaling increases NAADP and cADPR levels in the heart von Lewis, Alexander M, Aley, Parvinder K, Roomi, Ali, Thomas, Justyn M, Masgrau, Roser, Garnham, Clive, Shipman, Katherine, Paramore, Claire, Bloor-Young, Duncan, Sanders, Luke E L, Terrar, Derek A, Galione, Antony, Churchill, Grant C

Volltext